The null finding held up even when researchers sliced the data by geography, income, insurance type, and social vulnerability ...

Trump aims to accelerate the research, regulation, and integration of psychedelic-assisted therapies into US health care, ...

Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care.

A cruise-ship cluster with three deaths triggered international public health response, including environmental assessments, isolation measures, and medical evacuation of symptomatic passengers for ...

Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

Desai, MBBS, MD, assistant professor of thoracic medical oncology/head and neck medical oncology at Fox Chase Cancer Center ...

This randomized controlled trial (RCT) evaluated whether tailored cost information could reduce consumer inertia in selecting ...

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

Rising rates appear concentrated in hormone receptor–positive disease, aligning with later age at first birth, fewer ...

Community oncology leaders emphasized provider-first AI adoption, starting with clear use cases, defined guardrails, and ...

Since the historic approval of tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia in 2017, chimeric antigen receptor (CAR) T-cell therapies have altered the treatment paradigm ...